Journal
EMERGING INFECTIOUS DISEASES
Volume 26, Issue 6, Pages 1266-1273Publisher
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2606.200516
Keywords
-
Categories
Funding
- National Institute on Aging of the National Institutes of Health [1.719A1100625, R00AG049092, R24AI120942, AI99107, AI114657]
- National Institutes of Allergy and Infectious Diseases of the National Institutes of Health [1.719A1100625, R00AG049092, R24AI120942, AI99107, AI114657]
- University of Texas System
- Institute for Human Infections and Immunity at the University of Texas Medical Branch
- McLaughlin Fellowship Fund at the University of Texas Medical Branch
Ask authors/readers for more resources
The etiologic agent of an outbreak of pneumonia in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 in January 2020. A patient in the United States was given a diagnosis of infection with this virus by the state of Washington and the US Centers for Disease Control and Prevention on January 20, 2020. We isolated virus from nasopharyngeal and oropharyngeal specimens from this patient and characterized the viral sequence, replication properties, and cell culture tropism. We found that the virus replicates to high titer in Vero-CCL81 cells and Vero E6 cells in the absence of trypsin. We also deposited the virus into 2 virus repositories, making it broadly available to the public health and research communities. We hope that open access to this reagent will expedite development of medical countermeasures.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available